Myocardial resistance to ischemic and reperfusion injuries under conditions of chronic administration of opioid receptor agonists and antagonists

Yu B. Lishmanov, D. L. Stakheev, A. V. Krylatov, N. V. Naryzhnaya, L. N. Maslov, M. V. Ovchinnikov, F. Kolar

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Chronic treatment with opioid receptor ligands: nonselective peptide opioid receptor agonist dalargin (intraperitoneally in a dose of 1 mg/kg), selective nonpeptide κ-receptor agonist GR 89696 (subcutaneously in a dose of 0.03 mg/kg), nonselectrive nonpeptide antagonist quadazocine (subcutaneously in a dose of 3 mg/kg) or naltrexone (subcutaneously in a dose of 10 mg/kg) for 20 day had no effect of the incidence of ischemic ventricular arrhythmias and the size of necrotic zone after coronary occlusion and reperfusion in rats in vivo.

Original languageEnglish
Pages (from-to)696-699
Number of pages4
JournalBulletin of Experimental Biology and Medicine
Volume145
Issue number6
DOIs
Publication statusPublished - 19 Nov 2008

Fingerprint

Narcotic Antagonists
Opioid Receptors
Reperfusion Injury
Myocardial Reperfusion
Naltrexone
Peptide Receptors
Coronary Occlusion
Peptides
Rats
Cardiac Arrhythmias
Ligands
Incidence
GR 89696
quadazocine
Ala(2)-Arg(6)-enkephalin-leu

Keywords

  • Chronic treatment with opioid receptor agonists
  • Ischemia
  • Myocardium
  • Reperfusion

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Myocardial resistance to ischemic and reperfusion injuries under conditions of chronic administration of opioid receptor agonists and antagonists. / Lishmanov, Yu B.; Stakheev, D. L.; Krylatov, A. V.; Naryzhnaya, N. V.; Maslov, L. N.; Ovchinnikov, M. V.; Kolar, F.

In: Bulletin of Experimental Biology and Medicine, Vol. 145, No. 6, 19.11.2008, p. 696-699.

Research output: Contribution to journalArticle

Lishmanov, Yu B. ; Stakheev, D. L. ; Krylatov, A. V. ; Naryzhnaya, N. V. ; Maslov, L. N. ; Ovchinnikov, M. V. ; Kolar, F. / Myocardial resistance to ischemic and reperfusion injuries under conditions of chronic administration of opioid receptor agonists and antagonists. In: Bulletin of Experimental Biology and Medicine. 2008 ; Vol. 145, No. 6. pp. 696-699.
@article{2c99019cf1b74dd8840b929f5eebb84d,
title = "Myocardial resistance to ischemic and reperfusion injuries under conditions of chronic administration of opioid receptor agonists and antagonists",
abstract = "Chronic treatment with opioid receptor ligands: nonselective peptide opioid receptor agonist dalargin (intraperitoneally in a dose of 1 mg/kg), selective nonpeptide κ-receptor agonist GR 89696 (subcutaneously in a dose of 0.03 mg/kg), nonselectrive nonpeptide antagonist quadazocine (subcutaneously in a dose of 3 mg/kg) or naltrexone (subcutaneously in a dose of 10 mg/kg) for 20 day had no effect of the incidence of ischemic ventricular arrhythmias and the size of necrotic zone after coronary occlusion and reperfusion in rats in vivo.",
keywords = "Chronic treatment with opioid receptor agonists, Ischemia, Myocardium, Reperfusion",
author = "Lishmanov, {Yu B.} and Stakheev, {D. L.} and Krylatov, {A. V.} and Naryzhnaya, {N. V.} and Maslov, {L. N.} and Ovchinnikov, {M. V.} and F. Kolar",
year = "2008",
month = "11",
day = "19",
doi = "10.1007/s10517-008-0172-9",
language = "English",
volume = "145",
pages = "696--699",
journal = "Bulletin of Experimental Biology and Medicine",
issn = "0007-4888",
publisher = "Springer New York",
number = "6",

}

TY - JOUR

T1 - Myocardial resistance to ischemic and reperfusion injuries under conditions of chronic administration of opioid receptor agonists and antagonists

AU - Lishmanov, Yu B.

AU - Stakheev, D. L.

AU - Krylatov, A. V.

AU - Naryzhnaya, N. V.

AU - Maslov, L. N.

AU - Ovchinnikov, M. V.

AU - Kolar, F.

PY - 2008/11/19

Y1 - 2008/11/19

N2 - Chronic treatment with opioid receptor ligands: nonselective peptide opioid receptor agonist dalargin (intraperitoneally in a dose of 1 mg/kg), selective nonpeptide κ-receptor agonist GR 89696 (subcutaneously in a dose of 0.03 mg/kg), nonselectrive nonpeptide antagonist quadazocine (subcutaneously in a dose of 3 mg/kg) or naltrexone (subcutaneously in a dose of 10 mg/kg) for 20 day had no effect of the incidence of ischemic ventricular arrhythmias and the size of necrotic zone after coronary occlusion and reperfusion in rats in vivo.

AB - Chronic treatment with opioid receptor ligands: nonselective peptide opioid receptor agonist dalargin (intraperitoneally in a dose of 1 mg/kg), selective nonpeptide κ-receptor agonist GR 89696 (subcutaneously in a dose of 0.03 mg/kg), nonselectrive nonpeptide antagonist quadazocine (subcutaneously in a dose of 3 mg/kg) or naltrexone (subcutaneously in a dose of 10 mg/kg) for 20 day had no effect of the incidence of ischemic ventricular arrhythmias and the size of necrotic zone after coronary occlusion and reperfusion in rats in vivo.

KW - Chronic treatment with opioid receptor agonists

KW - Ischemia

KW - Myocardium

KW - Reperfusion

UR - http://www.scopus.com/inward/record.url?scp=56049095550&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=56049095550&partnerID=8YFLogxK

U2 - 10.1007/s10517-008-0172-9

DO - 10.1007/s10517-008-0172-9

M3 - Article

C2 - 19110553

AN - SCOPUS:56049095550

VL - 145

SP - 696

EP - 699

JO - Bulletin of Experimental Biology and Medicine

JF - Bulletin of Experimental Biology and Medicine

SN - 0007-4888

IS - 6

ER -